Login

Simeon Iheagwam's solo-GP fund supporting amazing founders|Simeon Iheagwam,Founder and Managing Partner,NOEMIS Ventures 00:10:00

Share On Facebook Share On Twitter

Founder & Managing Partner at NOEMIS Ventures

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploring Copper & Gold Potential: Quaterra's Nevada & Alaska Projects
00:10:00
Charlemagne Capital: World at key turning point|Julian Mayo,Co-CIO,The Charlemagne Fund Ltd
00:10:00
Giga Metals reports that the Turnagain Project in British Columbia had a good pre-feasibility study | MARK JARVIS, CEO & Chairman, Giga Metals Corporation (IE)
00:10:00
Letting Go: The Emotional Journey of Selling Your Business|Michael Bloch,Partner,Quiet Capital
00:10:00
Liontown Resources' Rapid Growth and Milestones: Managing Director David Richards at the One-to-One Conference
00:10:00
Disconnect Between Share Prices and Underlying Fundamentals: Colin Stewart of JC Clark Limited Highlights Opportunities in Canadian Companies
00:10:00
Navigating Economic Waters: Q2 Market Update 2022 | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
From Dropout to CEO: Steve Orenstein on His Path to Success | Steve Orenstein , CEO , Zoom2u Technologies Ltd.
00:10:00
Keith Farlinger on BDO's Global Vision: People Helping People Achieve Their Dreams | Keith Farlinger, CEO , BDO Global.
00:10:00
Positive Trends in China Internet Sector: Travel, E-Commerce, and Cloud Computing
00:10:00
Playbook to Evolving Your Product Genetics|Miles Grimshaw,General Partner,Benchmark
00:10:00
supporting the World's Best Entrepreneurs Scientists and Engineers|Andrew D Ive, Managing General Partner,Big Idea Ventures

© 2026 Nehu